Vyndamax Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Reddish brown, opaque, oblong (approximately 21 mm) capsule printed with "VYN 61" in white.
Each soft capsule contains 61 mg of micronized tafamidis.
Excipient with known effect: Each soft capsule contains no more than 44 mg of sorbitol (E 420).
Excipients/Inactive Ingredients: Capsule shell: Gelatine (E 441), Glycerine (E 422), Red iron oxide (E 172), Sorbitan, Sorbitol (E 420), Mannitol (E 421), Purified water.
Capsule contents: Macrogol 400 (E 1521), Polysorbate 20 (E 432), Povidone (K-value 90), Butylated hydroxytoluene (E 321).
Printing ink: (Opacode white), Ethyl alcohol, Isopropyl alcohol, Purified water, Macrogol 400 (E 1521), Polyvinyl acetate phthalate, Propylene glycol (E 1520), Titanium dioxide (E 171), Ammonium hydroxide (E 527) 28%.

tafamidis

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma